News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Schering adds DrKW for defence

Schering, the German pharmaceuticals group fighting off a €14.6bn ($17.4bn) hostile bid from local rival Merck, has added Dresdner Kleinwort Wasserstein to its defence team. Morgan Stanley is already advising.

A spokeswoman for DrKW confirmed the appointment.

WSJ Logo